Clinical characteristics | Cluster 1 (N = 247) | Cluster 2 (N = 213) | P value |
---|---|---|---|
Age (years, mean ± sd) | 54.96 ± 15.41 | 61.74 ± 15.29 | 3.07E−06a |
Gender (Male/Female) | 152/95 | 134/79 | 0.773b |
Pathologic_M (M0/M1/–) | 219/14/14 | 191/10/12 | 0.679b |
Pathologic_N (N0/N1/N2/N3/–) | 118/42/28/33/26 | 111/31/21/22/28 | 0.599b |
Pathologic_T (T0/T1/T2/T3/T4/–) | 20/33/51/54/44/45 | 3/8/26/36/107/33 | 2.893E−13b |
Pathologic_stage (I/II/III/IV/–) | 66/43/97/14/27 | 17/96/72/9/19 | 6.568E−12b |
Radiotherapy (Yes/No/–) | 35/212/0 | 14/198/1 | 0.00975b |
Tumor recurrence (Yes/No/–) | 45/107/95 | 44/100/69 | 0.899b |
Tumor metastatic (Yes/No) | 235/12 | 123/90 | 2.200E−16b |
Dead (Death/Alive) | 111/136 | 111/102 | 0.149b |
Overall survival time (months, mean ± sd) | 78.21 ± 71.12 | 42.07 ± 49.53 | 4.269E−10a |